Search AI Products and News

Today, on the second anniversary of Baichuan Intelligent's founding, the company's founder and CEO Wang Xiaochuan released an all-staff letter, reviewing the past two years' achievements and shortcomings, and clarifying the company's current and future development direction. Wang Xiaochuan emphasized that Baichuan Intelligent will firmly pursue its technological vision and business direction in the medical field, promoting the deep application of AI technology in the medical industry through the path of "creating doctors - changing paths - promoting medicine".

A significant advancement in Chinese medicine has been achieved with the recent clinical deployment of "Xiehe-Taichu," a rare disease AI model jointly developed by Peking Union Medical College Hospital and the Institute of Automation, Chinese Academy of Sciences. This marks a breakthrough in China's rare disease diagnostic technology and provides a new tool for improving clinical efficiency. The development of this AI model benefits from years of accumulated knowledge on rare diseases in China and the support of genetic testing data from the Chinese population. As the world's first rare disease model tailored to the characteristics of the Chinese population, it...